Last 1,743 INR
Change Today +10.15 / 0.59%
Volume 452.2K
DIVI On Other Exchanges
Symbol
Exchange
Natl India
As of 6:05 AM 11/26/14 All times are local (Market data is delayed by at least 15 minutes).

divi's laboratories ltd (DIVI) Snapshot

Open
1,728
Previous Close
1,733
Day High
1,754
Day Low
1,725
52 Week High
10/31/14 - 1,888
52 Week Low
12/10/13 - 1,095
Market Cap
231.4B
Average Volume 10 Days
149.6K
EPS TTM
58.26
Shares Outstanding
132.7M
EX-Date
07/31/14
P/E TM
29.9x
Dividend
20.00
Dividend Yield
1.15%
Current Stock Chart for DIVI'S LABORATORIES LTD (DIVI)

Related News

No related news articles were found.

divi's laboratories ltd (DIVI) Related Businessweek News

No Related Businessweek News Found

divi's laboratories ltd (DIVI) Details

Divi’s Laboratories Limited manufactures and sells active pharmaceutical ingredients (API) and intermediates for generics in India. The company also offers building blocks for peptides and nucleotides; carotenoids, such as apocarotenal, betacarotene, lycopene, astaxanthin, canthaxanthin, etc.; nutraceuticals; protected amino acids comprising BOC, FMOC, and CBZ; and novel ligands, including binol, binap, and others. The company also offers custom synthesis of API and advanced intermediates for discovery compounds to pharma companies. It also exports its products primarily to European and the American countries. The company was formerly known as Divi’s Research Center and changed its name to Divi’s Laboratories Limited in 1994. Divi’s Laboratories Limited was founded in 1990 and is headquartered in Hyderabad, India.

Founded in 1990

divi's laboratories ltd (DIVI) Top Compensated Officers

Chairman, Managing Direector and Member of Co...
Total Annual Compensation: 9.0M
President of Operations, Director of Operatio...
Total Annual Compensation: 7.8M
Executive Director and Member of Corporate So...
Total Annual Compensation: 8.4M
Director of Projects, Executive Director and ...
Total Annual Compensation: 7.8M
Compensation as of Fiscal Year 2014.

divi's laboratories ltd (DIVI) Key Developments

Divis Laboratories Ltd Announces Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2014

Divis Laboratories Ltd. announced unaudited standalone earnings results for the second quarter and six months ended September 30, 2014. For the quarter, the company reported net sales/income from operations of INR 8,297.7 million against INR 5,658.8 million for the same period previous year. Profit from operations before other income, interest & exceptional items was INR 2,775.4 million against INR 2,262.0 million for the same period of previous year. Profit from ordinary activities before tax was INR 2,926.5 million against INR 2,623.5 million for the same period of previous year. Net profit was INR 2,296.4 million or INR 17.30 per basic and diluted share compared to INR 2,049.3 million or INR 15.44 per basic and diluted share for the same period of previous year. For the six months, the company reported net sales/income from operations of INR 14,695.3 million against INR 10,817.6 million for the same period previous year. Profit from operations before other income, interest & exceptional items was INR 4,794.5 million against INR 4,025.0 million for the same period of previous year. Profit from ordinary activities before tax was INR 5,068.9 million against INR 4,916.6 million for the same period of previous year. Net profit was INR 3,975.7 million or INR 29.95 per basic and diluted share compared to INR 3,796.4 million or INR 28.60 per basic and diluted share for the same period of previous year.

Divi's Laboratories Limited to Report Q2, 2015 Results on Nov 01, 2014

Divi's Laboratories Limited announced that they will report Q2, 2015 results on Nov 01, 2014

Divi's Laboratories Limited, Board Meeting, Nov 01, 2014

Divi's Laboratories Limited, Board Meeting, Nov 01, 2014. Agenda: To consider and approve, the un-audited financial results for the second quarter and half-year ended September 30, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DIVI:IN 1,743.20 INR +10.15

DIVI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Biocon Ltd 460.10 INR -2.50
Dishman Pharmaceuticals & Chemicals Ltd 141.75 INR +2.40
Piramal Enterprises Ltd 810.20 INR -17.00
Shasun Pharmaceuticals Ltd 218.75 INR +1.60
Torrent Pharmaceuticals Ltd 1,026 INR +2.40
View Industry Companies
 

Industry Analysis

DIVI

Industry Average

Valuation DIVI Industry Range
Price/Earnings 28.7x
Price/Sales 8.8x
Price/Book 7.5x
Price/Cash Flow 25.6x
TEV/Sales 8.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DIVI'S LABORATORIES LTD, please visit www.divislaboratories.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.